Lamotrigine added to antipsychotic treatment for schizophrenia
About this title
Read the official source — NCT00071747This study evaluated the effectiveness of lamotrigine for people with schizophrenia.
Understand this study
What did researchers investigate?
This study evaluated the effectiveness of lamotrigine for people with schizophrenia.
Who was this study for?
This study was for people with schizophrenia. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
- Listed locations
- Little Rock and 31 more locationsSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
- Recruitment status
- Completed
- Enrollment listed in the registry
- 176
- Sponsor
- GlaxoSmithKline
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00071747
- Official title
Show the full official title
A Multi-Center, Double Blind, Placebo-controlled, Randomized, Parallel Group Evaluation of the Efficacy of a Flexible Dose of Lamotrigine Versus Placebo As Add-On Therapy In Schizophrenia
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
Little Rock · Garden Grove · La Mesa
28 more locations
- National City
- Oceanside
- Rosemead
- San Diego
- Hartford
- Maitland
- North Miami
- Granite City
- Glen Burnie
- Rockville
- Boston
- Reno
- Clementon
- Kenilworth
- Orangeburg
- Rochester
- Butner
- Charlotte
- Raleigh
- Beachwood
- Cleveland
- Lyndhurst
- Norristown
- Austin
- Bellaire
- DeSoto
- Midvale
- Milwaukee
Interested in joining this study?
Questions about this study
What did researchers investigate?
This study evaluated the effectiveness of lamotrigine for people with schizophrenia.
Who is behind this study?
The study sponsor is GlaxoSmithKline.
Did this study involve medication?
Yes. The study involved medication, including lamotrigine.
Who was this study for?
This study was for people with schizophrenia. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
